Education
About Us
Working with TipRanks
Follow Us
Zimmer Biomet Holdings (ZBH)
NYSE:ZBH
ZBH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$97.69 - $133.90
Previous CloseN/A
Volume487.31K
Average Volume (3M)1.97M
Market Cap
$20.70B
Enterprise Value$26.99B
Total Cash (Recent Filing)$542.80M
Total Debt (Recent Filing)$8.92B
Price to Earnings (P/E)23.5
Beta0.72
Next Earnings
May 06, 2025EPS Estimate
1.78Next Dividend Ex-Date
Mar 31, 2025Dividend Yield0.91%
Share Statistics
EPS (TTM)4.44
Shares Outstanding199,063,170
10 Day Avg. Volume1,789,129
30 Day Avg. Volume1,972,897
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)N/A
Price to Sales (P/S)2.73
Price to Cash Flow (P/CF)10.40
P/FCF Ratio9.40
Enterprise Value/Market Cap1.30
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit5.08
Enterprise Value/Ebitda10.75
Forecast
1Y Price Target
$120.85Price Target Upside16.21% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering21
---
Bulls Say, Bears Say
Bulls Say
Product LaunchesA host of new product launches in key segments can drive growth acceleration.
Strategic AcquisitionThe deal to acquire Paragon 28 makes strategic sense and will increase ZBH's corporate-wide growth rate.
Bears Say
Market PerformanceZBH lost market share in the recon, knee, and hip segments.
---
Ownership Overview
0.08% Insiders
35.21% Mutual Funds
19.74% Other Institutional Investors
18.55% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ZBH FAQ
What was Zimmer Biomet Holdings’s price range in the past 12 months?
Zimmer Biomet Holdings lowest stock price was $97.69 and its highest was $133.90 in the past 12 months.
What is Zimmer Biomet Holdings’s market cap?
Zimmer Biomet Holdings’s market cap is $20.70B.
When is Zimmer Biomet Holdings’s upcoming earnings report date?
Zimmer Biomet Holdings’s upcoming earnings report date is May 06, 2025 which is in 61 days.
How were Zimmer Biomet Holdings’s earnings last quarter?
Zimmer Biomet Holdings released its earnings results on Feb 06, 2025. The company reported $2.31 earnings per share for the quarter, beating the consensus estimate of $2.295 by $0.015.
Is Zimmer Biomet Holdings overvalued?
According to Wall Street analysts Zimmer Biomet Holdings’s price is currently Undervalued.
Does Zimmer Biomet Holdings pay dividends?
Zimmer Biomet Holdings pays a Quarterly dividend of $0.239 which represents an annual dividend yield of 0.91%. See more information on Zimmer Biomet Holdings dividends here
What is Zimmer Biomet Holdings’s EPS estimate?
Zimmer Biomet Holdings’s EPS estimate is 1.78.
How many shares outstanding does Zimmer Biomet Holdings have?
Zimmer Biomet Holdings has 199,063,170 shares outstanding.
What happened to Zimmer Biomet Holdings’s price movement after its last earnings report?
Zimmer Biomet Holdings reported an EPS of $2.31 in its last earnings report, beating expectations of $2.295. Following the earnings report the stock price went down -5.136%.
Which hedge fund is a major shareholder of Zimmer Biomet Holdings?
Currently, no hedge funds are holding shares in ZBH
---
Zimmer Biomet Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$120.85 (16.21% Upside)
$120.85 (16.21% Upside)
Blogger Sentiment
Bullish
ZBH Sentiment 83%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 2.0M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 3.0%
Last 30 Days ▲ 1.4%
Last 30 Days ▲ 1.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.43%
12-Months-Change
Fundamentals
Return on Equity
7.25%
Trailing 12-Months
Asset Growth
-0.61%
Trailing 12-Months
Company Description
Zimmer Biomet Holdings
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company engages in designing, manufacturing and marketing orthopedic reconstructive products; biologics, sports medicine, extremities and trauma products; spine, dental implants, bone healing, craniomaxillofacial and thoracic products; and related surgical products.
---
ZBH Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a balanced view, highlighting consistent revenue growth, strategic acquisitions, and strong performance in the S.E.T. segment, but also noting challenges such as ERP issues and FX headwinds impacting margins.Read More>---
ZBH Net sales Breakdown
57.81% U.S.
42.19% International
---
ZBH Stock 12 Month Forecast
Average Price Target
$120.85
▲(16.21% Upside)
Technical Analysis
Best Analysts Covering ZBH
1 Year
1 Year Success Rate
30/45 ratings generated profit
1 Year Average Return
+5.50%
assigned a buy rating 4 months ago
Copying Steven Lichtman's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +5.50% per trade.
---